U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Development & Approval Process (CBER)
  4. Labeling for CBER-Regulated Products
  5. Compliance Actions on Biologics Advertising & Promotional Labeling
  1. Labeling for CBER-Regulated Products

Compliance Actions on Biologics Advertising & Promotional Labeling

A Warning Letter is an informal, advisory correspondence, issued to achieve voluntary compliance and to establish prior notice. 

An Untitled Letter is an initial correspondence with regulated industry that cites violations that do not meet the threshold of regulatory significance for a Warning Letter.

Key Resources

Related Information

Back to Top